A qualitative study of MT-2 users found that mole darkening and new mole formation were among the most commonly reported longer-term effects (Evans-Brown et al., 2021)
Our pharmaceutical partner will coordinate with your insurer to get you the medication at the best price possible
Here is what you should know before you decide
Companies are developing oral GLP-1-targeting medicines for obesity in the hope of coming up with an easier-to-dose alternative to the current generation of weekly, injectable drugs led by Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) and Eli Lilly's GIP/GLP-1 agonist Zepbound (tirzepatide)
Food & drinks to avoid: Steer clear of sugary foods and beverages, as well as added sugar alcohols such as erythritol, which can sometimes trigger digestive discomfort and loose stools
It is offered in a safe, effective, and easy-to-use custom formulation